Last reviewed · How we verify
NCT05929313
Scoreflex TRIO - Scoring PTCA Catheter
NA trial testing OrbusNeich Scoreflex TRIO in Coronary Arteriosclerosis in 210 participants. Completed in 29 May 2024.
30 April 2024
Quick facts
| Lead sponsor | OrbusNeich |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 210 |
| Start date | 27 April 2023 |
| Primary completion | 30 April 2024 |
| Estimated completion | 29 May 2024 |
| Sites | 4 locations across China |
Drugs / interventions tested
- OrbusNeich Scoreflex TRIO
- OrbusNeich Scoreflex NC
Conditions studied
- Coronary Arteriosclerosis — all drugs for Coronary Arteriosclerosis →
Sponsor
OrbusNeich — full company profile →
Who can join
Adults 18 to 80, any sex, with Coronary Arteriosclerosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To evaluate the acute safety and device procedural success of the Scoreflex TRIO Scoring PTCA catheters versus Scoreflex NC Scoring PTCA catheters in subjects with stenotic coronary arteries during percutaneous coronary intervention.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05929313
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Coronary Arteriosclerosis
Currently open trials in the same condition.
- NCT06701968 — Effects of a Healthy Nordic Diet on Atherosclerosis in Patients with Coronary Heart Disease · NA · recruiting
- NCT06075602 — COMPLEX Registry - a Prospective COhort Study to Describe the Management and Outcomes of Patients Presenting with CompLE · recruiting
- NCT04988685 — SIROOP Registry - A Prospective Registry Study to Evaluate the Outcomes of Coronary Artery Disease Patients Treated With · recruiting
- NCT03349385 — Registry of Secondary Revascularization · active not recruiting
- NCT04827316 — Clinical Utility and Outcome Prediction of Cardiovascular Computed Tomography (PREDICT-CT) · recruiting
Other OrbusNeich trials
Trials by the same sponsor.
- NCT06358508 — Sapphire 3 CTO Study · NA · completed
- NCT03763747 — Scoreflex NC - Scoring PTCA Catheter · NA · completed
- NCT03052530 — Sapphire II PRO US Clinical Study · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05929313 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by OrbusNeich
- Last refreshed: 26 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05929313.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing